CA2085364A1 - Complexe metal-radionucleide comprenant des ligands d'isonitrile - Google Patents
Complexe metal-radionucleide comprenant des ligands d'isonitrileInfo
- Publication number
- CA2085364A1 CA2085364A1 CA002085364A CA2085364A CA2085364A1 CA 2085364 A1 CA2085364 A1 CA 2085364A1 CA 002085364 A CA002085364 A CA 002085364A CA 2085364 A CA2085364 A CA 2085364A CA 2085364 A1 CA2085364 A1 CA 2085364A1
- Authority
- CA
- Canada
- Prior art keywords
- metal
- complex
- radionuclide
- kit
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000003446 ligand Substances 0.000 title claims abstract description 15
- 150000002527 isonitriles Chemical class 0.000 title claims abstract description 9
- 229910052751 metal Inorganic materials 0.000 claims abstract description 24
- 239000002184 metal Substances 0.000 claims abstract description 24
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 5
- 229910052738 indium Inorganic materials 0.000 claims abstract description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 5
- 125000002947 alkylene group Chemical group 0.000 claims abstract description 4
- 229910052804 chromium Inorganic materials 0.000 claims abstract description 4
- 229910052745 lead Inorganic materials 0.000 claims abstract description 4
- 230000007935 neutral effect Effects 0.000 claims abstract description 4
- 229910052713 technetium Inorganic materials 0.000 claims abstract description 4
- 229910052802 copper Inorganic materials 0.000 claims abstract description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims abstract description 3
- 229910052733 gallium Inorganic materials 0.000 claims abstract description 3
- 229910052742 iron Inorganic materials 0.000 claims abstract description 3
- 229910052707 ruthenium Inorganic materials 0.000 claims abstract description 3
- 229910052785 arsenic Inorganic materials 0.000 claims abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract 2
- 229910052748 manganese Inorganic materials 0.000 claims abstract 2
- 239000000203 mixture Substances 0.000 claims description 16
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- 239000013522 chelant Substances 0.000 claims description 8
- 239000004615 ingredient Substances 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 7
- 239000002738 chelating agent Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 229940121896 radiopharmaceutical Drugs 0.000 claims description 5
- 239000012217 radiopharmaceutical Substances 0.000 claims description 5
- 230000002799 radiopharmaceutical effect Effects 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 239000003638 chemical reducing agent Substances 0.000 claims description 3
- GKLVYJBZJHMRIY-OUBTZVSYSA-N Technetium-99 Chemical compound [99Tc] GKLVYJBZJHMRIY-OUBTZVSYSA-N 0.000 claims description 2
- 230000037396 body weight Effects 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims 3
- 239000000243 solution Substances 0.000 claims 3
- PBRRIXIAWUGGMO-UHFFFAOYSA-N 3-isocyano-1,1-dimethoxypropane Chemical compound COC(OC)CC[N+]#[C-] PBRRIXIAWUGGMO-UHFFFAOYSA-N 0.000 claims 2
- 239000012876 carrier material Substances 0.000 claims 1
- 239000012895 dilution Substances 0.000 claims 1
- 238000010790 dilution Methods 0.000 claims 1
- 230000005855 radiation Effects 0.000 claims 1
- 229940056501 technetium 99m Drugs 0.000 claims 1
- 210000000056 organ Anatomy 0.000 description 17
- 150000001875 compounds Chemical class 0.000 description 14
- 210000004072 lung Anatomy 0.000 description 8
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HOXINJBQVZWYGZ-UHFFFAOYSA-N fenbutatin oxide Chemical compound C=1C=CC=CC=1C(C)(C)C[Sn](O[Sn](CC(C)(C)C=1C=CC=CC=1)(CC(C)(C)C=1C=CC=CC=1)CC(C)(C)C=1C=CC=CC=1)(CC(C)(C)C=1C=CC=CC=1)CC(C)(C)C1=CC=CC=C1 HOXINJBQVZWYGZ-UHFFFAOYSA-N 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- LJJFNFYPZOHRHM-UHFFFAOYSA-N 1-isocyano-2-methoxy-2-methylpropane Chemical compound COC(C)(C)C[N+]#[C-] LJJFNFYPZOHRHM-UHFFFAOYSA-N 0.000 description 2
- 101150041968 CDC13 gene Proteins 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241001504519 Papio ursinus Species 0.000 description 2
- 229920000388 Polyphosphate Polymers 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 230000009918 complex formation Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 235000011180 diphosphates Nutrition 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 239000001205 polyphosphate Substances 0.000 description 2
- 235000011176 polyphosphates Nutrition 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- -1 tetramethylene, propylene Chemical group 0.000 description 2
- MDYOLVRUBBJPFM-UHFFFAOYSA-N tropolone Chemical compound OC1=CC=CC=CC1=O MDYOLVRUBBJPFM-UHFFFAOYSA-N 0.000 description 2
- GPYKJDYMMUIUFG-UHFFFAOYSA-N 1-(2-Furanyl)-1,3-butanedione Chemical compound CC(=O)CC(=O)C1=CC=CO1 GPYKJDYMMUIUFG-UHFFFAOYSA-N 0.000 description 1
- KNMLZCYLMYOYBD-KTTJZPQESA-N 1-isocyano-2-methoxy-2-methylpropane;technetium-99 Chemical compound [99Tc].COC(C)(C)C[N+]#[C-].COC(C)(C)C[N+]#[C-].COC(C)(C)C[N+]#[C-].COC(C)(C)C[N+]#[C-].COC(C)(C)C[N+]#[C-].COC(C)(C)C[N+]#[C-] KNMLZCYLMYOYBD-KTTJZPQESA-N 0.000 description 1
- CVBUKMMMRLOKQR-UHFFFAOYSA-N 1-phenylbutane-1,3-dione Chemical compound CC(=O)CC(=O)C1=CC=CC=C1 CVBUKMMMRLOKQR-UHFFFAOYSA-N 0.000 description 1
- BSXCLFYNJYBVPM-UHFFFAOYSA-N 1-thiophen-2-ylbutane-1,3-dione Chemical compound CC(=O)CC(=O)C1=CC=CS1 BSXCLFYNJYBVPM-UHFFFAOYSA-N 0.000 description 1
- CDTVZHPSMCIDDK-UHFFFAOYSA-N 2-isocyanopropanal Chemical compound O=CC(C)[N+]#[C-] CDTVZHPSMCIDDK-UHFFFAOYSA-N 0.000 description 1
- MKTWPDZHFUXUOY-UHFFFAOYSA-N 3-isocyanopropanal Chemical compound O=CCC[N+]#[C-] MKTWPDZHFUXUOY-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- ODPOAESBSUKMHD-UHFFFAOYSA-L 6,7-dihydrodipyrido[1,2-b:1',2'-e]pyrazine-5,8-diium;dibromide Chemical compound [Br-].[Br-].C1=CC=[N+]2CC[N+]3=CC=CC=C3C2=C1 ODPOAESBSUKMHD-UHFFFAOYSA-L 0.000 description 1
- 240000005020 Acaciella glauca Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 208000005156 Dehydration Diseases 0.000 description 1
- 239000005630 Diquat Substances 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical group OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- HWZUDASOMGNLSM-UHFFFAOYSA-N O=P1OCOP(=O)O1 Chemical compound O=P1OCOP(=O)O1 HWZUDASOMGNLSM-UHFFFAOYSA-N 0.000 description 1
- 241001163743 Perlodes Species 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 241000251221 Triakidae Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 125000003963 dichloro group Chemical group Cl* 0.000 description 1
- 125000005594 diketone group Chemical group 0.000 description 1
- HCUYBXPSSCRKRF-UHFFFAOYSA-N diphosgene Chemical compound ClC(=O)OC(Cl)(Cl)Cl HCUYBXPSSCRKRF-UHFFFAOYSA-N 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- RXPRRQLKFXBCSJ-UHFFFAOYSA-N dl-Vincamin Natural products C1=CC=C2C(CCN3CCC4)=C5C3C4(CC)CC(O)(C(=O)OC)N5C2=C1 RXPRRQLKFXBCSJ-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- WABPQHHGFIMREM-AHCXROLUSA-N lead-203 Chemical compound [203Pb] WABPQHHGFIMREM-AHCXROLUSA-N 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- NIQQIJXGUZVEBB-UHFFFAOYSA-N methanol;propan-2-one Chemical compound OC.CC(C)=O NIQQIJXGUZVEBB-UHFFFAOYSA-N 0.000 description 1
- 229940102859 methylene diphosphonate Drugs 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 101150015886 nuc-1 gene Proteins 0.000 description 1
- HJZKOAYDRQLPME-UHFFFAOYSA-N oxidronic acid Chemical compound OP(=O)(O)C(O)P(O)(O)=O HJZKOAYDRQLPME-UHFFFAOYSA-N 0.000 description 1
- 229960004230 oxidronic acid Drugs 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- RXPRRQLKFXBCSJ-GIVPXCGWSA-N vincamine Chemical compound C1=CC=C2C(CCN3CCC4)=C5[C@@H]3[C@]4(CC)C[C@](O)(C(=O)OC)N5C2=C1 RXPRRQLKFXBCSJ-GIVPXCGWSA-N 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
- C07F13/005—Compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0476—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from monodendate ligands, e.g. sestamibi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL90201569.2 | 1990-06-18 | ||
| EP90201569 | 1990-06-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2085364A1 true CA2085364A1 (fr) | 1991-12-19 |
Family
ID=8205034
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002085364A Abandoned CA2085364A1 (fr) | 1990-06-18 | 1991-06-14 | Complexe metal-radionucleide comprenant des ligands d'isonitrile |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0548245A1 (fr) |
| JP (1) | JPH05508162A (fr) |
| AU (1) | AU8542591A (fr) |
| CA (1) | CA2085364A1 (fr) |
| WO (1) | WO1991019516A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2679452B1 (fr) * | 1991-07-22 | 1993-11-12 | Cis Bio International | Produit radiopharmaceutique ayant notamment un tropisme cerebral, comportant un complexe nitruro d'un metal de transition, et son procede de preparation. |
| DK1286704T3 (da) * | 2000-06-02 | 2014-09-22 | Univ Texas | Ethylendicystein (EC)-glucose analoge konjugater |
| US10925977B2 (en) | 2006-10-05 | 2021-02-23 | Ceil>Point, LLC | Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1305160C (fr) * | 1985-12-23 | 1992-07-14 | Paul Louis Bergstein | Isonitriles de type ether et complexes radioetiquettes de ceux-ci |
| US4885100A (en) * | 1987-09-11 | 1989-12-05 | E. I. Du Pont De Nemours And Company | Tris(isonitrile)copper(I) adducts for preparing radionuclide complexes |
-
1991
- 1991-06-14 JP JP91515592A patent/JPH05508162A/ja active Pending
- 1991-06-14 WO PCT/US1991/004251 patent/WO1991019516A1/fr not_active Application Discontinuation
- 1991-06-14 EP EP91917284A patent/EP0548245A1/fr not_active Withdrawn
- 1991-06-14 CA CA002085364A patent/CA2085364A1/fr not_active Abandoned
- 1991-06-14 AU AU85425/91A patent/AU8542591A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1991019516A1 (fr) | 1991-12-26 |
| AU8542591A (en) | 1992-01-07 |
| JPH05508162A (ja) | 1993-11-18 |
| EP0548245A1 (fr) | 1993-06-30 |
| EP0548245A4 (fr) | 1994-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0123504B1 (fr) | Complexes de technétium-99m avec des oximes d'alkylèneamines | |
| JPH0662446B2 (ja) | ▲上９▼▲上９▼▲上ｍ▼Ｔｃの陽イオン性親脂性錯体を製造するためのキット | |
| JPS62201363A (ja) | 放射線標識エーテル置換イソニトリル錯化合物を含有する心筋像形成剤 | |
| US5286853A (en) | Boron-gadolinium compounds and method of conducting imaging and/or neutron capture therapy with same | |
| Berning et al. | In vitro and in vivo characterization of a 99mTc complex with tris (hydroxymethyl) phosphine (THP) | |
| US5037631A (en) | Technetium-99M complex for examinating the renal function | |
| AU633597B2 (en) | 99m tc(iii) myocardial imaging agents that are effective in humans | |
| CA2085364A1 (fr) | Complexe metal-radionucleide comprenant des ligands d'isonitrile | |
| US5407658A (en) | Analogs of cytochalasin B as radiopharmaceuticals for nuclear imaging of trans-membrane glucose transport | |
| JPH11504002A (ja) | 診断医薬品及び治療医薬品としての使用のためのヒドロキシアルキルホスフィン化合物並びにその製造方法 | |
| US4957728A (en) | Kit for preparing Tc (III)-99m myocardial imaging agents that are effective in humans | |
| CN113583066B (zh) | 一种甘露糖衍生物及其应用 | |
| EP0201005B1 (fr) | Agents de visualisation myocardiale 99mTc(III) non réductibles in vivo | |
| US4781912A (en) | Cationic complex of technetium-99m. | |
| KR20120120990A (ko) | 레늄-188에 기초한 인간에서의 간암 치료용 조성물 및 이러한 조성물의 제조 방법 | |
| WO1995004114A1 (fr) | Complexes de sulfates de tris(isonitrile)cuivre(i) utilises dans la preparation de radionuclides | |
| US4584186A (en) | Radiolabelled metallocene derivatives | |
| Matsumoto et al. | 62Cu-labeled bifunctional radiopharmaceuticals with metabolizable ester groups | |
| EP0138384B1 (fr) | Visualisation d'infarctus cardiaques à l'aide de métaux radioactifs compléxés avec des dérivés phosphonates | |
| Jackson et al. | Technetium-99m labelling of bis-oxime ligands | |
| AU3275293A (en) | Bicyclopolyazamacrocyclocarboxylic acid complexes, their conjugates processes for their preparation, and use as radiopharmaceuticals | |
| Satpati et al. | Preparation and Evaluation of 99mTc (CO) 3-Labeled Pentadecanoic Acid Derivative and Its Suspension in Lipiodol | |
| Huang et al. | Syntheses, Characterization and Biodistribution of Technetium-99m-Labeled Tetradentate Schiff Base Complexes | |
| Valliant | Synthesis and NMR spectroscopy of tripeptide derived biomolecules for site specific radiopharmaceuticals | |
| McOrmond | Six Tc-99m labelled dibasic acids: an investigation of their potential use as scintiscanning agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued | ||
| FZDE | Discontinued |
Effective date: 19941214 |